Study guide
7.1 Ocular Pathogens & Routes of Disease Transmission
IJCAHPO Certified Retina Technician CRT
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview: Current CRT Requirements & Blueprint
Exam Overview: Current Requirements, Scope & Study Plan
2 Chapter 1: History Taking, Triage & Clinical Documentation
1.1 Comprehensive Ophthalmic & Medical History for Retina Patients 1.2 Telephone Triage, Urgent Symptoms & Emergency Scheduling 1.3 Scribing, Electronic Health Records & Retinal Billing Codes
3 Chapter 2: Visual Assessment & Low Vision Rehabilitation
2.1 Standardized Visual Acuity Testing & Optotypes 2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP 2.3 Low Vision Definitions, Optical Devices & Patient Counseling
4 Chapter 3: Pupil Assessment & Visual Field Testing
3.1 Pupillary Examination & Relative Afferent Pupillary Defect 3.2 Confrontation Fields & Automated Perimetry in Retina 3.3 Amsler Grid Testing & Metamorphopsia Monitoring
5 Chapter 4: Tonometry & Ocular Motility
4.1 Goldmann Applanation & Handheld Tonometry Techniques 4.2 Tonometer Disinfection, Calibration & Post-Procedure IOP Monitoring 4.3 Ocular Motility Assessment, Strabismus & Alignment Testing
6 Chapter 5: Diagnostic Ophthalmic Ultrasound
5.1 Ophthalmic B-Scan Echography for Posterior Segment Pathology 5.2 Standardized A-Scan Echography & Optical Biometry
7 Chapter 6: Slit Lamp, Electrophysiology & Supplemental Testing
6.1 Slit Lamp Biomicroscopy, Illumination & Fundus Lenses 6.2 Color Vision Assessment & Hertel Exophthalmometry 6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG
8 Chapter 7: Ophthalmic Microbiology & Infection Control
7.1 Ocular Pathogens & Routes of Disease Transmission 7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
9 Chapter 8: General Retinal Pharmacology & Therapeutics
8.1 Ocular Drug Delivery Methods & Routes of Administration 8.2 Mydriatics, Cycloplegics & Diagnostic Ophthalmic Dyes 8.3 Anesthetics, Glaucoma Agents & Prescription Verification
10 Chapter 9: Anti-VEGF Therapies, Steroids & Retinal Toxicity
9.1 Anti-VEGF Agents & Neovascular Retinal Diseases 9.2 Corticosteroids, Sustained-Release Implants & AREDS Supplements 9.3 Systemic Medication Retinal Toxicity & Plaquenil Screening
11 Chapter 10: Surgical Assisting & Intravitreal Procedures
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks 10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols 10.3 Surgical Instrument Handling, Tray Setup & Sterilization
12 Chapter 11: Patient Services, Education & Clinical Care
11.1 Patient Education, Chronic Disease Counseling & Treatment Adherence 11.2 Special Needs Accommodations, Patient Diversity & Interpersonal Skills 11.3 Ophthalmic Emergencies, First Aid & Clinical Care Coordination 11.4 Clinic Operations, Research Support, Forms & Referrals
13 Chapter 12: General Ocular Anatomy & Retinal Physiology
12.1 Ocular Anatomy, Orbit & Posterior Segment Architecture 12.2 Ten Retinal Layers, Photoreceptors & Macular Anatomy 12.3 Ocular Blood Supply, Microcirculation & Vitreoretinal Interface 12.4 Body Systems, Ocular Adnexa & Medical Terminology
14 Chapter 13: Retinal Pathology & Systemic Disease Manifestations
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions 13.2 Diabetic Retinopathy & Systemic Diseases Affecting the Retina 13.3 Peripheral Retinal Degenerations, Tears & Detachments
15 Chapter 14: Ophthalmic Optics & Lensometry
14.1 Principles of Ophthalmic Optics & Refraction 14.2 Manual & Automated Lensometry Techniques
16 Chapter 15: Fundus Photography & Ophthalmic Angiography
15.1 Fundus Photography Techniques & Fundus Autofluorescence 15.2 Fluorescein Angiography Principles, Phases & Image Interpretation 15.3 Indocyanine Green Angiography & Angiographic Complication Management
17 Chapter 16: Optical Coherence Tomography (OCT & OCT-A)
16.1 OCT Principles, Scan Acquisition & Artifact Recognition 16.2 Structural OCT Interpretation: Retinal Fluid & Biomarkers 16.3 Optical Coherence Tomography Angiography (OCT-A) Principles & Flow
18 Chapter 17: Equipment Maintenance, Ethics & Regulatory Compliance
17.1 Equipment Maintenance, Calibration Schedules & Clinic Safety 17.2 Medical Ethics, Scope of Practice & Informed Consent 17.3 Patient Privacy, HIPAA Standards & Hazardous Waste Disposal
7.1 Ocular Pathogens & Routes of Disease Transmission
Key Takeaways Explain This Topic AI
Post-procedure infection often originates from the patient's ocular-surface flora; oral flora, contaminated equipment or products, trauma, and sterile-field breaks are additional exogenous routes.
Viridans-group streptococci can cause aggressive endophthalmitis and may originate from oral flora; injection teams follow current masking, no-talking, antisepsis, and sterile-field policy to reduce droplet contamination.
Bacterial, fungal, viral, and parasitic diseases have recognizable associations, but pain, timing, appearance, and prognosis vary and do not identify an organism by themselves.
Candida is a common cause of endogenous fungal endophthalmitis in patients with bloodstream risk factors; culture, examination, and systemic evaluation establish the organism and source.
The technician documents objective findings and risk factors, supports ordered specimen handling, and escalates suspected infection promptly without choosing antimicrobial therapy.
Last updated: September 2026
Ocular Pathogens and Transmission
The interior of the eye is normally protected from environmental organisms. Infection can become vision- and health-threatening when microbes enter through a wound, needle tract, surgical incision, diseased cornea, contaminated product, or bloodstream. A technician recognizes risk, preserves asepsis, documents the pattern, and activates the clinical pathway; culture, molecular testing, examination, and licensed judgment establish the diagnosis.
Routes of transmission
Ocular surface and direct inoculation: Coagulase-negative staphylococci, Staphylococcus aureus , and Cutibacterium acnes can arise from skin, lids, lashes, or conjunctiva and enter during trauma or an intraocular procedure.
Droplet contamination: Viridans-group streptococci are associated with oral flora. Follow current masking, no-talking, antisepsis, and sterile-field policy for intraocular procedures.
Contaminated item or environment: A touched syringe tip, compromised package, reused single-patient product, ineffective disinfection, or contaminated compounded lot can expose one or many patients. A cluster is an urgent safety and public-health signal.
Trauma or contiguous spread: Soil, plant material, a retained foreign body, contact-lens-related keratitis, or an infected filtering bleb can introduce bacteria or fungi.
Hematogenous spread: Bacteremia, fungemia, endocarditis, intravenous drug use, indwelling lines, abdominal infection, immune suppression, or another systemic focus can seed choroid or retina.
Bacterial patterns
Coagulase-negative staphylococci are common ocular-surface organisms and frequent isolates after intraocular surgery or injection. S. aureus , streptococci, enterococci, and gram-negative bacilli can produce aggressive inflammation and poor outcomes, but severity overlaps. Cutibacterium acnes is associated with delayed, indolent pseudophakic infection and a capsular plaque. Pseudomonas is important in contaminated solutions, trauma, and severe keratitis. Klebsiella pneumoniae is classically linked with invasive liver-abscess syndrome and endogenous ocular infection, particularly in reported endemic populations. Culture and susceptibility data guide treatment; morphology or timing alone does not.
Concerning findings include increasing pain, redness, photophobia, hypopyon, vitreous haze, discharge, wound change, or vision decline after a procedure. Infection can occasionally be less painful or have an atypical time course, so do not dismiss a change because it falls outside a memorized window.
Fungal patterns
Candida can cause endogenous chorioretinal infection in patients with candidemia risk, central venous access, parenteral nutrition, abdominal surgery, broad antimicrobial exposure, immune suppression, or injection drug use. Creamy chorioretinal lesions with overlying vitreous opacities are a classic association, not a laboratory identification.
Filamentous fungi such as Aspergillus or Fusarium may follow vegetative trauma, corneal infection, contaminated material, or systemic immune compromise. Subretinal lesions, vascular invasion, keratitis, or severe inflammation require urgent specialist evaluation. Fungal transport media, incubation, and molecular testing are laboratory-specific.
Viral and parasitic patterns
Herpes simplex and varicella-zoster viruses can cause acute retinal necrosis with peripheral necrotizing retinitis, vascular inflammation, vitreous inflammation, and later detachment risk. Progressive outer retinal necrosis is associated with severe immune compromise and may show limited inflammation. Cytomegalovirus retinitis occurs especially with substantial immune suppression and can show granular or hemorrhagic necrotizing patterns. Immune status and therapy change presentation; colloquial fundus descriptions are memory aids, not diagnostic proof.
Toxoplasma gondii commonly causes focal necrotizing retinochoroiditis, often near an old scar with overlying vitritis. Toxocara can produce a granuloma and vitreoretinal traction, particularly in younger patients. Parasite exposure history and appearance support a differential, while clinician evaluation and testing establish the cause.
Prevention and response
Use hand hygiene, standard precautions, required personal protective equipment, approved room and equipment disinfection, intact sterile supplies, ophthalmic antisepsis, and current procedural controls. A dropper or syringe tip that contacts lashes, skin, a glove, or another nonsterile surface is contaminated. Announce the break and replace the item.
For suspected infection, record onset, procedure or trauma, eye, symptoms, medications, immune status, systemic illness, travel or exposure when relevant, and objective findings. Notify the clinician promptly. Prepare specimen containers and transport only from the current laboratory protocol. Do not start, stop, dilute, or substitute an antibacterial, antiviral, antifungal, or antiparasitic drug independently.
Pattern Important association Technician action
Acute post-procedure inflammation with worsening vision Bacterial or sterile causes among the differential Escalate promptly; do not diagnose by timing or pain alone
Chorioretinal lesions with bloodstream risk Endogenous bacterial or fungal spread Relay systemic history and support urgent ocular and medical evaluation
Necrotizing retinitis with immune compromise Viral, fungal, bacterial, or parasitic possibilities Document immune and medication history and route immediately
Contamination or infection cluster Product, compounding, device, or process concern Stop affected workflow, preserve lot and device data, and activate safety reporting